This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 217 Users Online

Non-PVC IV Bags Market

Market Study on Non-PVC IV Bags: Surge in malnutrition-led population to augment the demand for Non-PVC IV Bags

Global Non-PVC IV Bags Market by Product Type (Single Chamber, Multi Chamber) made by Ethylene Vinyl Acetate (EVA), Polypropylene, and Copolyester Ether Material types

Market Snapshot

A newly released Non-PVC IV Bags Market analysis report by Persistence Market Research shows that global sales of Non-PVC IV Bags in 2022 was held at US$ 1.8 Bn. With a CAGR of 12.8% during 2023 - 2033, the market is projected to reach a valuation of US$ 6.5 Bn by 2033. Single Chamber is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 12.9% during 2023 – 2033.

Attribute

Details

Global Non-PVC IV Bags Market (2023)

US$ 2 Bn

Global Non-PVC IV Bags Market (2033)

US$ 6.5 Bn

Global Non-PVC IV Bags Market CAGR (2023 – 2033)

12.8%

U.S. Non-PVC IV Bags Market CAGR (2023 – 2033)

13.3%

Key Companies Profiled

  • Baxter
  • B. Braun Melsungen AG
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • JW Life Science
  • RENOLIT
  • PolyCine GmbH
  • Sealed Air
  • ANGIPLAST PVT. LTD
  • Shanghai Solve Care Co Ltd.
  • Kraton Corporation
  • Jiangxi Sanxin Medtec Co., Ltd.
Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Revenue of Non-PVC IV Bags Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the Non-PVC IV Bags Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Non-PVC IV Bags Market increased at around 11.8% CAGR.

Non-PVC IV bags, also known as intravenous treatment bags, are used to avoid dehydration and maintain blood pressure, as well as to administer medications and nourishment to patients who are unable to eat on their own.

Because of their environmental friendliness, non-PVC IV bags are becoming increasingly popular. Phthalate IV bags are being used less often across the world, and several governments and government organizations are taking measures to decrease their use. This corresponds to increasing non-PVC IV bag usage as a result; higher market growth is expected for empty IV bags.

The increased prevalence of malnutrition on a worldwide scale is also driving the demand for Non-PVC IV bags, which is in line with expanding government activities to improve healthcare and awareness. One of the primary reasons driving the growth of the non-PVC IV bags market is the global increase in cancer incidence, which would imply a high growth rate throughout the projected period.

Non-PVC IV bags serve an important role in the operating room, and demand for such containers is likely to rise throughout the forecast period as the number of patients in healthcare facilities increase. Furthermore, these bags have solved the drawbacks of PVC bags, which frequently experienced drug-container interactions.

The fact that these bags come in a variety of patterns is also helping to drive the non-PVC IV bag industry forward. The need for non-PVC bags is steadily rising as a result of more strict rules related to hospital-acquired disease, improper dosage distribution, and the necessity for new IV containers. Traditional IV containers caused medication interaction with the packing material and were inconvenient to carry, particularly glass vials.

The introduction of non-PVC IV bags alleviated these issues. These bags are more commonly used in targeted medication delivery and chemotherapy. Because the plasticizers in these containers are prone to interact with the medicine, industry companies are currently exploring materials that can be utilized to create IV bags without the usage of plasticizers.

Furthermore, with the rise in hospital-acquired infections, regulatory organizations have turned their attention to the quality of treatment, resulting in an increase in the usage of non-PVC IV bags.

Increased knowledge of preventative measures to prevent mistakes, such as the distribution of an incorrect dose, will propel the market forward. The advantages of non-PVC IV bags, such as their lightweight and reduced danger of contamination, will help drive the industry forward.

The market would rise due to the rising prevalence of chronic illnesses and the use of non-PVC IV bags in chemotherapy and targeted medication administration. The market's growth will be accelerated by the introduction of unique materials and varied bag designs. Moreover, when compared to PVC bags, the advantages of non-PVC IV bags for frozen mixes, such as high instability and durability, would benefit the market over the forecast period.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Which Factors are Propelling Non-PVC IV Bags Demand?

Non-PVC IV bags are primarily used for parenteral feeding and chemotherapy applications. These materials can be used for several applications, including cold and frozen storage. As a result, non-PVC IV bags' broad application is likely to drive market expansion throughout the projection period.

Furthermore, strict regulatory standards relating to PVC IV bags have resulted in a rise in the usage of non-PVC materials in both the medical and non-medical industries. The worldwide shift away from PVC materials offers huge development opportunities, attracting both manufacturers and investors to the industry.

In parenteral feeding services, non-PVC IV bags are becoming more frequent. They have a significant need for multi-chambered containers since the composition differs from patient to patient. The need for customized IV bag providers is projected to increase as more specialized therapeutic solutions are introduced.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Region-wise Analysis

Which Region is projected to Offer the Largest Opportunity for Non-PVC IV Bags Market?

In 2022, North America held the largest share of the global Non-PVC IV Bags market due to rising actions taken by the authorities, growing rigidness of regulatory institutions towards patient wellbeing, growing expenditure on research, rising cases of cancer and diarrhea, and the presence of multiple market players. Furthermore, strict restrictions aimed at improving patient safety, as well as an increase in demand for Eva infusion bags, will drive demand for non-PVC IV bags in the area.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Country-wise Analysis

U.S. Non-PVC IV Bags Market Analysis

By the end of 2033, the United States is expected to have the largest market share of US$ 2.9 Bn. It previously grew at a significant CAGR of 12.9% from 2018 to 2022 and is expected to grow at a CAGR of 13.3% over the forecasted period.

In North America, the United States has the highest share of the Non-PVC IV Bags Market. Furthermore, the Non-PVC IV Bags Market in the country is likely to be fueled by the rising usage of innovative medication delivery technologies and technological advancements.

U.K. Non-PVC IV Bags Market Analysis

The market in the U.K. is expected to reach a valuation of US$ 281 Mn by 2033, growing at a CAGR of 13% during 2023 – 2033. The market is projected to gross an absolute dollar opportunity of US$ 198 Mn during the forecast period.

Japan Non-PVC IV Bags Market Analysis

In Japan, the market is expected to reach a valuation of US$ 331 Mn by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 244 Mn, growing at a CAGR of 14.4%.

South Korea Non-PVC IV Bags Market Analysis

The market in South Korea is projected to grow at a CAGR of 15% during 2023 – 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 113 Mn and reach US$ 151 Mn by 2033.

Category-wise Insights

Which Product Type is expected to contribute most for Non-PVC IV Bags Providers?

Single Chamber IV Bags commanded the largest revenue, grew at a CAGR of 12.2% during 2018-22, and is now forecasted to grow at a CAGR of 12.9% throughout the forecasted period.

Because of their widespread use in IV drips and other combinations, the single-chambered segment is expected to dominate the worldwide non-PVC IV bags market. The advantages of a single-chambered section are ease of handling, transportation, and disposal. Furthermore, the growing number of point-of-care and home-care institutions is driving increased demand for single-chamber bags.

Which Material Type is expected to contribute most for Non-PVC IV Bags Providers?

The market through Ethylene Vinyl Acetate (EVA) commanded the largest revenue and grew at a CAGR of nearly 12.9% during 2018-22, and is forecasted to grow at a CAGR of 15.8% throughout the forecast period.

Ethylene-vinyl acetate (EVA) is a vinyl-ethylene acetate copolymer. It is a flexible and long-lasting thermoplastic with a high degree of transparency and nearly no odor. EVA offers a number of appealing qualities, including its cheap cost, wide range of polarities, and adherence to non-porous substrates, which are likely to fuel segment expansion throughout the projection period.

Competitive Analysis

Some of the players in Non-PVC IV Bags Market include Baxter, B. Braun Melsungen AG, Pfizer, Inc., Fresenius Kabi AG, JW Life Science, RENOLIT, PolyCine GmbH, Sealed Air, ANGIPLAST PVT. LTD, Shanghai Solve Care Co Ltd., Kraton Corporation, and Jiangxi Sanxin Medtec Co., Ltd.

Some of the recent developments of key Non-PVC IV Bags providers are as follows:

  • In April 2022, Fresenius Kabi announced the introduction of two new Heparin Sodium presentations in ready-to-administer and handy Freeflex IV bags in the United States.
  • In 2022, Fagron Sterile Services announced the launch of a PVC-free, environmentally friendly IV bag product line.
  • In May 2019, Sihuan Pharmaceutical Holdings Group Ltd and its affiliated firm Beijing Ruiye Drugs Manufacture Co. Ltd jointly introduced the non-PVC solid-liquid double chamber bag for ceftazidime/sodium chloride injection.

Similarly, recent developments related to companies in the Non-PVC IV Bags Market have been tracked by the team at Persistence Market Research, which are available in the full report.

Scope for Non-PVC IV Bags Market Analysis

By Product Type

  • Single Chamber
  • Multi Chamber

By Material Type

  • Ethylene Vinyl Acetate (EVA)
  • Polypropylene
  • Copolyester Ether
  • Other Material Types

By Content

  • Frozen Mixture
  • Liquid Mixture

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

- Companies Covered in This Report -

  • Baxter
  • B. Braun Melsungen AG
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • JW Life Science
  • Renolit
  • PolyCine GmbH.
  • Sealed Air
  • Shanghai Xin Gen Eco-Technologies Co., Ltd.
  • Angiplast Pvt. Ltd.
  • Shanghai Solve Care Co Ltd.
  • Kraton Corporation

- Frequently Asked Questions -

The global Non-PVC IV Bags Market is worth more than US$ 1.8 Bn at present.

The market value of the Non-PVC IV Bags Market is projected to increase at a CAGR of around 12.8% during 2023 – 2033.

The market value of the Non-PVC IV Bags Market increased at a CAGR of around 11.8% during 2018 – 2022.

Increased malnutrition rates, a global increase in cancer incidence, and an increase in hospital-acquired infections are contributing to the market expansion.

The market for Non-PVC IV Bags Market in China is projected to expand at a CAGR of around 13.3% during 2023 – 2033.

While the market in South Korea is expected to grow at nearly 15%, the market in Japan is projected to register a CAGR of nearly 14.4% during 2023 - 2033.

Google translate